Usefulness of tissue doppler imaging-myocardial performance index in the evaluation of diastolic dysfunction and heart failure with preserved ejection fraction

Clinical Cardiology

Volumn 34, Issue 8, 2011, Pages 494-499

  Kim, Hyungseop ^a   Yoon, Hyuck Jun ^a   Park, Hyoung Seob ^a   Cho, Yun Kyeong ^a   Nam, Chang Wook ^a   Hur, Seung Ho ^a   Kim, Yoon Nyun ^a   Kim, Kwon Bae ^a  

^a Dongsan Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; ARTICLE; CLINICAL EVALUATION; COMPARATIVE STUDY; CORONARY ARTERY BLOOD FLOW; DIASTOLIC DYSFUNCTION; DOPPLER ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART CONTRACTION; HEART DEATH; HEART EJECTION FRACTION; HEART FAILURE; HEART INDEX; HEART MUSCLE RELAXATION; HEART PERFORMANCE; HEART VENTRICLE EJECTION TIME; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; TISSUE DOPPLER IMAGING;

AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DISEASE-FREE SURVIVAL; ECHOCARDIOGRAPHY, DOPPLER, COLOR; FEMALE; HEART FAILURE, DIASTOLIC; HOSPITALIZATION; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MITRAL VALVE; MYOCARDIAL CONTRACTION; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REPUBLIC OF KOREA; STROKE VOLUME; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 80051547547     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20932     Document Type: Article

References (27)

1. Tei C, Dujardin KS, Hodge DO, et al. Doppler index combining systolic and diastolic myocardial performance: clinical value in cardiac amyloidosis. J Am Coll Cardiol. 1996; 28: 658-664. (Pubitemid 26288647)
2. Ascione L, De Michele M, Accadia M, et al. Myocardial global performance index as a predictor of in-hospital cardiac events in patients with first myocardial infarction. J Am Soc Echocardiogr. 2003; 16: 1019-1023. (Pubitemid 37210927)
3. Arnlov J, Ingelsson E, Riserus U, et al. Myocardial performance index, a Doppler-derived index of global left ventricular function, predicts congestive heart failure in elderly men. Eur Heart J. 2004; 25: 2220-2225. (Pubitemid 39592423)
4. Orem C, Kucukosmanoglu M, Hacihasanoglu A, et al. Association of Doppler-derived myocardial performance index with albuminuria in patients with diabetes. J Am Soc Echocardiogr. 2004; 17: 1185-1190. (Pubitemid 39388910)
5. Okawa M, Kitaoka H, Matsumura Y, et al. Functional assessment by myocardial performance index (Tei index) correlates with plasma brain natriuretic peptide concentration in patients with hypertrophic cardiomyopathy. Circ J. 2005; 69: 951-957. (Pubitemid 41124264)
6. Abhayaratna WP, Seward JB, Appleton CP, et al. Left atrial size: physiologic determinants and clinical applications. J Am Coll Cardiol. 2006; 47: 2357-2363. (Pubitemid 43866385)
7. Rakowski H, Appleton C, Chan KL, et al. Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography: from the Investigators of Consensus on Diastolic Dysfunction by Echocardiography. J Am Soc Echocardiogr. 1996; 9: 736-760.
8. McKee PA, Castelli WP, McNamara PM, et al. The natural history of congestive heart failure: the Framingham study. N Engl J Med. 1971; 285: 1441-1446.
9. Paulus WJ, Tschope C, Sanderson JE, et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J. 2007; 28: 2539-2550. (Pubitemid 47614269)
10. Kindermann M., How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J. 2007; 28: 2686; author reply 2687. (Pubitemid 350071516)
11. Borlaug BA, Lam CS, Roger VL, et al. Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction. J Am Coll Cardiol. 2009; 54: 410-418.
12. Melenovsky V, Borlaug BA, Rosen B, et al. Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: the role of atrial remodeling/dysfunction. J Am Coll Cardiol. 2007; 49: 198-207. (Pubitemid 46070209)
13. Watanabe T, Iwai-Takano M, Oikawa M, et al. Optimal noninvasive assessment of diastolic heart failure in patients with atrial fibrillation: comparison of tissue doppler echocardiography, left atrium size, and brain natriuretic peptide. J Am Soc Echocardiogr. 2008; 21: 689-696.
14. Emery WT, Jadavji I, Choy JB, et al. Investigating the European Society of Cardiology Diastology Guidelines in a practical scenario. Eur J Echocardiogr. 2008; 9: 685-691.
15. Surucu H, Tatli E, Degirmenci A, et al. Subtle systolic dysfunction may be associated with the tendency to develop diastolic heart failure in patients with preserved left ventricular ejection fraction. Echocardiography. 2009; 26: 365-370.
16. Kasner M, Westermann D, Steendijk P, et al. Utility of Doppler echocardiography and tissue Doppler imaging in the estimation of diastolic function in heart failure with normal ejection fraction: a comparative Doppler-conductance catheterization study. Circulation. 2007; 116: 637-647. (Pubitemid 47356348)
17. Nishikage T, Nakai H, Lang RM, et al. Subclinical left ventricular longitudinal systolic dysfunction in hypertension with no evidence of heart failure. Circ J. 2008; 72: 189-194. (Pubitemid 351413354)
18. King G, Foley JB, Royse CF, et al. Myocardial stiffness and the timing difference between tissue Doppler imaging Ea and peak mitral valve opening can distinguish physiological hypertrophy in athletes from hypertrophic cardiomyopathy. Eur J Echocardiogr. 2006; 7: 423-429. (Pubitemid 44645058)
19. Executive summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail. 2006; 12: 10-38.
20. Hunt SA., ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. 2005; 46: e1-e82. (Pubitemid 41316530)
21. Rojo EC, Rodrigo JL, Perez de Isla L, et al. Disagreement between tissue Doppler imaging and conventional pulsed wave Doppler in the measurement of myocardial performance index. Eur J Echocardiogr. 2006; 7: 356-364. (Pubitemid 44283932)
22. Jarnert C, Mejhert M, Ring M, et al. Doppler tissue imaging in congestive heart failure patients due to diastolic or systolic dysfunction: a comparison with Doppler echocardiography and the atrio-ventricular plane displacement technique. Eur J Heart Fail. 2000; 2: 151-160. (Pubitemid 30407555)
23. Rudko R, Przewlocki T, Pasowicz M, et al. IVRTa /IVRT index is a useful tool for detection of elevated left ventricular filling pressure in patients with preserved ejection fraction. Echocardiography. 2008; 25: 473-481. (Pubitemid 351623862)
24. Dujardin KS, Tei C, Yeo TC, et al. Prognostic value of a Doppler index combining systolic and diastolic performance in idiopathic-dilated cardiomyopathy. Am J Cardiol. 1998; 82: 1071-1076. (Pubitemid 28507090)
25. Yusuf S, Pfeffer MA, Swedberg K, et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet. 2003; 362: 777-781. (Pubitemid 37093918)
26. Massie BM, Carson PE, McMurray JJ, et al. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med. 2008; 359: 2456-2467.
27. Flather MD, Shibata MC, Coats AJ, et al. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J. 2005; 26: 215-225. (Pubitemid 40222359)